SCHEMBL19620539

SCHEMBL19620539

NC1=C(OS(=O)Cc2ccccc2)C(=O)C(c2ccccc2F)O1

nearest known ligand 0.33

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 1/20 0.33
THRB P10828 1/20 0.33
POLB P06746 1/20 0.33
MAPT P10636 1/20 0.33
EPHX2 P34913 1/20 0.31
KDM1A O60341 1/20 0.30
MAOA P21397 1/20 0.30
MAOB P27338 1/20 0.30
HTR2C P28335 1/20 0.30
HTR2B P41595 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19620683 0.92 HTR2C (0.32) CYP1A2CYP3A4CYP2C19KDM4EPOLB
SCHEMBL19620597 0.89 DPP4 (0.38) CYP1A2CYP3A4CYP2C19KDM4EPOLB
SCHEMBL22902013 0.89 CYP1A2 (0.33) CYP1A2CYP3A4CYP2C19KDM4EPOLB
SCHEMBL19620692 0.86 DPP4 (0.38) CYP1A2CYP3A4CYP2C19KDM4EPOLB
SCHEMBL20368268 0.85 HTR2C (0.34) CYP1A2CYP3A4CYP2C19KDM4EPOLB
SCHEMBL19620621 0.84 MAPT (0.49) CYP1A2CYP3A4CYP2C19KDM4EALDH1A1
SCHEMBL15627599 0.83 KDM4E (0.41) KDM4EPOLBMAPTEPHX2KDM1A
SCHEMBL19620599 0.83 SMN1; SMN2 (0.33) POLBKDM1A
SCHEMBL19620645 0.83 KDM4E (0.36) CYP1A2CYP3A4CYP2C19KDM4EPOLB
SCHEMBL22902028 0.82 HTR2A (0.34) CYP1A2CYP3A4CYP2C19HTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2897607-B1 INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER RHODE ISLAND HOSPITAL (US) 2017-11-22 EP disclosed